190 related articles for article (PubMed ID: 37367101)
41. Riboflavin Targets the Cellular Metabolic and Ribosomal Pathways of Candida albicans
Lei J; Huang J; Xin C; Liu F; Zhang J; Xie Y; Mao Y; Chen W; Song Z
Microbiol Spectr; 2023 Feb; 11(1):e0380122. PubMed ID: 36625571
[TBL] [Abstract][Full Text] [Related]
42. Extracellular Vesicles Regulate Biofilm Formation and Yeast-to-Hypha Differentiation in Candida albicans.
Honorato L; de Araujo JFD; Ellis CC; Piffer AC; Pereira Y; Frases S; de Sousa Araújo GR; Pontes B; Mendes MT; Pereira MD; Guimarães AJ; da Silva NM; Vargas G; Joffe L; Del Poeta M; Nosanchuk JD; Zamith-Miranda D; Dos Reis FCG; de Oliveira HC; Rodrigues ML; de Toledo Martins S; Alves LR; Almeida IC; Nimrichter L
mBio; 2022 Jun; 13(3):e0030122. PubMed ID: 35420476
[TBL] [Abstract][Full Text] [Related]
43. Erg6 Acts as a Downstream Effector of the Transcription Factor Flo8 To Regulate Biofilm Formation in Candida albicans.
Jin X; Luan X; Xie F; Chang W; Lou H
Microbiol Spectr; 2023 Jun; 11(3):e0039323. PubMed ID: 37098889
[TBL] [Abstract][Full Text] [Related]
44. In vitro and in vivo analysis of monotherapy and dual therapy with ethyl caffeate and fluconazole on virulence factors of Candida albicans and systemic candidiasis.
Wang T; Pan M; Xiao N; Wu J; Wang Q; Cheng T; Yan G; Wu D; Li N; Shao J
J Glob Antimicrob Resist; 2021 Dec; 27():253-266. PubMed ID: 34700054
[TBL] [Abstract][Full Text] [Related]
45. The role of Candida albicans SPT20 in filamentation, biofilm formation and pathogenesis.
Tan X; Fuchs BB; Wang Y; Chen W; Yuen GJ; Chen RB; Jayamani E; Anastassopoulou C; Pukkila-Worley R; Coleman JJ; Mylonakis E
PLoS One; 2014; 9(4):e94468. PubMed ID: 24732310
[TBL] [Abstract][Full Text] [Related]
46. Role of filamentation in Galleria mellonella killing by Candida albicans.
Fuchs BB; Eby J; Nobile CJ; El Khoury JB; Mitchell AP; Mylonakis E
Microbes Infect; 2010 Jun; 12(6):488-96. PubMed ID: 20223293
[TBL] [Abstract][Full Text] [Related]
47. Optimum Inhibition of Amphotericin-B-Resistant
Touil HFZ; Boucherit K; Boucherit-Otmani Z; Khoder G; Madkour M; Soliman SSM
Biomolecules; 2020 Feb; 10(2):. PubMed ID: 32098224
[No Abstract] [Full Text] [Related]
48. Dracorhodin perchlorate inhibits biofilm formation and virulence factors of Candida albicans.
Yang LF; Liu X; Lv LL; Ma ZM; Feng XC; Ma TH
J Mycol Med; 2018 Mar; 28(1):36-44. PubMed ID: 29477784
[TBL] [Abstract][Full Text] [Related]
49. Candida albicans the main opportunistic pathogenic fungus in humans.
Macias-Paz IU; Pérez-Hernández S; Tavera-Tapia A; Luna-Arias JP; Guerra-Cárdenas JE; Reyna-Beltrán E
Rev Argent Microbiol; 2023; 55(2):189-198. PubMed ID: 36411138
[TBL] [Abstract][Full Text] [Related]
50. ADH1 promotes Candida albicans pathogenicity by stimulating oxidative phosphorylation.
Song Y; Li S; Zhao Y; Zhang Y; Lv Y; Jiang Y; Wang Y; Li D; Zhang H
Int J Med Microbiol; 2019 Sep; 309(6):151330. PubMed ID: 31471070
[TBL] [Abstract][Full Text] [Related]
51. Antifungal activity and potential mechanism of Asiatic acid alone and in combination with fluconazole against Candida albicans.
Wang Y; Lu C; Zhao X; Wang D; Liu Y; Sun S
Biomed Pharmacother; 2021 Jul; 139():111568. PubMed ID: 33845374
[TBL] [Abstract][Full Text] [Related]
52. Magnolol as a potent antifungal agent inhibits
Xie Y; Hua H; Zhou P
Front Cell Infect Microbiol; 2022; 12():935322. PubMed ID: 35937692
[TBL] [Abstract][Full Text] [Related]
53. Novel Sulfones with Antifungal Properties: Antifungal Activities and Interactions with Candida spp. Virulence Factors.
Gizińska M; Staniszewska M; Ochal Z
Mini Rev Med Chem; 2019; 19(1):12-21. PubMed ID: 30246638
[TBL] [Abstract][Full Text] [Related]
54. A curcumin-sophorolipid nanocomplex inhibits Candida albicans filamentation and biofilm development.
Rajasekar V; Darne P; Prabhune A; Kao RYT; Solomon AP; Ramage G; Samaranayake L; Neelakantan P
Colloids Surf B Biointerfaces; 2021 Apr; 200():111617. PubMed ID: 33592455
[TBL] [Abstract][Full Text] [Related]
55. Inhibitory Effect of Resveratrol on Candida albicans Biofilm Formation.
Okamoto-Shibayama K; Yoshida A; Ishihara K
Bull Tokyo Dent Coll; 2021 Mar; 62(1):1-6. PubMed ID: 33583879
[TBL] [Abstract][Full Text] [Related]
56. Lactobacillus rhamnosus inhibits Candida albicans virulence factors in vitro and modulates immune system in Galleria mellonella.
Ribeiro FC; de Barros PP; Rossoni RD; Junqueira JC; Jorge AO
J Appl Microbiol; 2017 Jan; 122(1):201-211. PubMed ID: 27727499
[TBL] [Abstract][Full Text] [Related]
57. Unraveling the anti-virulence potential and antifungal efficacy of 5-aminotetrazoles using the zebrafish model of disseminated candidiasis.
Radakovic N; Nikolić A; Jovanović NT; Stojković P; Stankovic N; Šolaja B; Opsenica I; Pavic A
Eur J Med Chem; 2022 Feb; 230():114137. PubMed ID: 35077918
[TBL] [Abstract][Full Text] [Related]
58. In vitro interactions between farnesol and fluconazole, amphotericin B or micafungin against Candida albicans biofilms.
Katragkou A; McCarthy M; Alexander EL; Antachopoulos C; Meletiadis J; Jabra-Rizk MA; Petraitis V; Roilides E; Walsh TJ
J Antimicrob Chemother; 2015 Feb; 70(2):470-8. PubMed ID: 25288679
[TBL] [Abstract][Full Text] [Related]
59.
Ke CL; Liao YT; Lin CH
Virulence; 2021 Dec; 12(1):281-297. PubMed ID: 33427576
[No Abstract] [Full Text] [Related]
60. Evaluation of citrus pectin capped copper sulfide nanoparticles against Candidiasis causing Candida biofilms.
Al-Enazi NM; Alsamhary K; Ameen F
Environ Res; 2023 May; 225():115599. PubMed ID: 36898420
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
